Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6017

Zymeworks and Jazz tout HER2 bispecific success in first Phase 3 readout

$
0
0
Zymeworks and Jazz Pharmaceuticals said that the addition of their HER2 bispecific Ziihera helped stave off disease progression in certain patients with gastroesophageal adenocarcinoma — a type of cancer that occurs in the stomach, esophagus and ...

Viewing all articles
Browse latest Browse all 6017

Trending Articles